Author

David Miller

Observed names: D Miller, D. MILLER, D. Miller, Miller, David

Institution: University College London

Observed institutions: University of Siena, Montreal Neurological Institute and Hospital, Medical University of Graz, University Hospital of Basel, Vall d'Hebron Hospital Universitari, IRCCS Ospedale San Raffaele, National Hospital for Neurology and Neurosurgery, Centre Hospitalier Universitaire de Rennes, UCL Queen Square Institute of Neurology, University College London, Imperial College London, Indiana State University, Amsterdam UMC Location Vrije Universiteit Amsterdam

OpenAlex ID: A5108802446

Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria.

1997 · G Edan, D Miller, et al. · Journal of Neurology Neurosurgery & Psychiatry · 425

Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis

1994 · T. Moreau, N. Scolding, et al. · The Lancet · 186

Guidelines for using proton MR spectroscopy in multicenter clinical MS studies

2007 · N. De Stefano, M. Filippi, et al. · Neurology · 120

MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain

2007 · for the MAGNIMS network, A. Seewann, et al. · Journal of Neurology · 104

Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT

2013 · G. Edan, L. Kappos, et al. · Journal of Neurology Neurosurgery & Psychiatry · 82

CAMPATH-1H in multiple sclerosis

1996 · Th Moreau, A Coles, et al. · Multiple Sclerosis Journal · 52

Superior Sagittal Sinus Thrombosis After Internal Jugular Vein Cannulation

1991 · P.H. STEPHENS, G. LENNOX, et al. · British Journal of Anaesthesia · 40

Serial gadolinium-enhanced and magnetization transfer imaging to investigate the relationship between the duration of blood-brain barrier disruption and extent of demyelination in new multiple sclerosis lesions

1999 · Nicholas Silver, Ming Lai, et al. · Journal of Neurology · 30

Safety and Tolerability of BG-12 in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS): Analyses From the CONFIRM Study (S41.005)

2012 · J. T. Phillips, R. Fox, et al. · Neurology · 6

Critical care neurology

1999 · David Miller, Eric C. Raps · 1

When the wild things are: Defining mammalian diel activity and plasticity

2026 · SDZWA Admin, Kadambari Devarajan, et al. · San Diego Zoo Wildlife Alliance

Redefining Value in Healthcare: The Necessary Shift Towards Patient-Reported Outcome Measures (PROMs) in Clinical Practice

2025 · Miller, David · Medicine insights.

End Point Committee terms of reference

2015 · Susan Ball, Jane Vickery, et al.

Inflammation, Demyelination, and Axonal Degeneration: Three Aspects of the Pathogenesis of Multiple Sclerosis Revealed by Campath-1H Treatment

2004 · A. J. Coles, M. G. Wing, et al. · Springer eBooks

Magnetresonanztomographie bei multipler Sklerose

2000 · M. Sailer, N. Bodammer, et al. · Klinische Neurophysiologie

Fortschritte bei der kernspintomographischen Darstellung des N. opticus

1995 · A. Gass, G. Barker, et al. · Verhandlungen der Deutschen Gesellschaft für Neurologie

Quantitative kernspintomographische Analyse bei Multipler Sklerose mit Magnetisation Transfer

1995 · A. Gass, G. Barker, et al. · Verhandlungen der Deutschen Gesellschaft für Neurologie

Works count: 17

Citation count: 1,046

H-index: 8

I10-index: 8